Pyrazole compounds and thrombopoietin receptor activators

Details Pyrazole compounds and thrombopoietin receptor activators Pyrazole compounds and thrombopoietin receptor activators

2011-06-14

2011-06-14

Solola, Taofiq A (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S365700

Reexamination Certificate

active

07960425

ABSTRACT:
A compound represented by the formula (I) (wherein R1, R2, R3and R4are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.

REFERENCES:
patent: 2003/0195231 (2003-10-01), Takemoto et al.
patent: 2004/0063764 (2004-04-01), Takemoto et al.
patent: 2004/0077697 (2004-04-01), Koshio et al.
patent: 2004/0082626 (2004-04-01), Takemoto et al.
patent: 2005/0153977 (2005-07-01), Sugasawa et al.
patent: 1 207 155 (2002-05-01), None
patent: 10-72492 (1998-03-01), None
patent: 11-1477 (1999-01-01), None
patent: 11-152276 (1999-06-01), None
patent: 2001-97948 (2001-04-01), None
patent: 2003/238565 (2003-08-01), None
patent: WO 96/40189 (1996-12-01), None
patent: WO 96/40750 (1996-12-01), None
patent: WO 98/25965 (1998-06-01), None
patent: WO 99/11262 (1999-03-01), None
patent: WO 00/35446 (2000-06-01), None
patent: WO 00/66112 (2000-11-01), None
patent: WO 01/07423 (2001-02-01), None
patent: WO 01/17349 (2001-03-01), None
patent: WO 01/21180 (2001-03-01), None
patent: WO 01/34585 (2001-05-01), None
patent: WO 01/39773 (2001-06-01), None
patent: WO 01/53267 (2001-07-01), None
patent: WO 01/89457 (2001-11-01), None
patent: WO 02/49413 (2002-06-01), None
patent: WO 02/059099 (2002-08-01), None
patent: WO 02/59100 (2002-08-01), None
patent: WO 02/062775 (2002-08-01), None
patent: WO 02/085343 (2002-10-01), None
patent: WO 03/062233 (2003-07-01), None
patent: 2004/033433 (2004-04-01), None
patent: WO 2004/033433 (2004-04-01), None
patent: 2004/108683 (2004-12-01), None
patent: WO 2004/108683 (2004-12-01), None
patent: 2006/064957 (2006-06-01), None
patent: WO 2006/064957 (2006-06-01), None
U.S. Appl. No. 12/492,435, filed Jun. 26, 2009, Owada, et al.
U.S. Appl. No. 12/303,436, filed Dec. 4, 2008, Miyaji, et al.
Jose E. Cardier, “Effects of Megakaryocyte Growth and Development Factor (Thrombopoietin) on Liver Endothelial Cells in Vitro”, Microvascular Research, vol. 58, 1999, pp. 108-113.
Maria Felice Brizzi, et al., “Thrombopoietin Stimulates Endothelial Cell Motility and Neoangiogenesis by a Platelet-Activating Factor-Dependent Mechanism”, Circulation Research, vol. 84, 1999, pp. 785-796.
“Blood”, Journal of the American Society of Hematology, vol. 98, No. 11, Nov. 16, 2001, pp. 71a-72a and a cover page.

Affiliated with

Also associated with

Rating

Pyrazole compounds and thrombopoietin receptor activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazole compounds and thrombopoietin receptor activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole compounds and thrombopoietin receptor activators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2712040